DPIIT recognised startup Government of India
Startup India
DCM Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.07 Cr
▲ 323% YoY
Net profit · FY 2024
₹2.81 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹3.46 Lakh
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹16.67 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About DCM Pharma Private Limited
Data last updated:
DCM Pharma Private Limited is a private limited company based in Chandigarh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2020PTC042985. Its GSTIN is 04AAHCD7400K1ZT (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumit Kumar and Abhinav Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 165 Basement Sector 38 C, Chandigarh, India – 160036.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.07 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.81 Lakh (net margin 2.6%) and EBITDA of ₹3.46 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
The company is associated with 1 brand: DCM Pharma Pvt Ltd. As per MCA filings, the company has open charges of ₹16.67 Lakh on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it.
For more details, the company can be reached via its website formulations.in.
Company details
CIN U51909CH2020PTC042985
Registration Number 042985
Incorporation Date 13 May 2020
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Sumit Kumar Director Abhinav Aggarwal Director Recognitions & Rankings of DCM Pharma
Contact details
DCM Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its website is formulations.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSCO 165 Basement Sector 38 C, Chandigarh, India – 160036
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of DCM Pharma Private Limited, buy the company report.
Comprehensive company report
DCM Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
DCM Pharma operates one associated brand: DCM Pharma Pvt Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical drug supply, distribution, and trading services in India. | formulations.in |
Business activity
The main business activity of DCM Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of DCM Pharma Private Limited, buy the company report.
Financials of DCM Pharma Private Limited
FY 2025 filings availableDCM Pharma Private Limited reported revenue of ₹1.07 Cr (up 323% YoY) for FY 2024.
Revenue · FY 2024
₹1.07 Cr ▲ 323%
Net profit · FY 2024
₹2.81 Lakh margin 2.6%
EBITDA · FY 2024
₹3.46 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 323%
3 years · compounded
▲ 108%
EBITDA CAGR growth
1 year
▲ 283%
3 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 323% growth in the latest year. EBITDA rose 283% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.46 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.81 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.2% | |||
| Net Profit Margin | 2.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of DCM Pharma Private Limited, buy the company report.
Board of directors of DCM Pharma Private Limited
DCM Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar | Director | 13 May 2020 | 6 Years 5 Months | Current |
| Abhinav Aggarwal | Director | 13 May 2020 | 6 Years 5 Months | Current |
Peer comparison
DCM Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exclusive Automobiles Private Limited | ₹1.07 Cr (FY 2025) | 2.0% | Delhi, India | |||
| Naturegro Seeds Private Limited | ₹1.07 Cr (FY 2025) | 2.0% | Bulandshahar, Uttar Pradesh, India | |||
| Collate Dealers Private Limited | ₹1.07 Cr (FY 2025) | -100.0% | Kolkata, West Bengal, India | |||
| Securex Solutions Private Limited | ₹1.07 Cr (FY 2025) | -24.0% | Delhi, India | |||
| Rustagi Infrastructure Private Limited | ₹1.07 Cr (FY 2025) | -29.0% | Thane, Maharashtra, India | |||
| DCM Pharma Private Limitedthis company | ₹1.07 Cr (FY 2024) | ₹2.81 Lakh | 2.6% | 323.0% | Chandigarh, India | |
| Shivkhori Commodities Private Limited | ₹1.07 Cr (FY 2025) | 9.0% | Kolkata, West Bengal, India | |||
| Leo United Industries India Private Limited | ₹1.07 Cr (FY 2025) | 1940.0% | Mumbai, Maharashtra, India | |||
| Super Surgical Devices Private Limited | ₹1.07 Cr (FY 2025) | 156.0% | Sonipat, Haryana, India | |||
| Wildorchid India Bioscience Private Limited | ₹1.07 Cr (FY 2025) | 0.0% | Noida, Uttar Pradesh, India | |||
| Astrochem Technologies Private Limited | ₹1.07 Cr (FY 2024) | 89.0% | Gurgaon, Haryana, India |
To see the full peer comparison of DCM Pharma Private Limited, buy the company report.
Auditor
DCM Pharma Private Limited is audited by DINESH VERMANI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DINESH VERMANI | FY 2023 | 084460 |
Shareholding
The shareholding of DCM Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of DCM Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.67 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2025 | 101047048 | Hdfc Bank Limited | ₹8.67 Lakh | Open | |
| 31 Dec 2024 | 101049518 | Hdfc Bank Limited | ₹8 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
DCM Pharma Private Limited has 5 court cases on record: 3 filed by DCM Pharma, 2 filed against it. All cases are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Pharmonix Pharmaceutical Pvt Ltd and 1 other | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ang Life Sciences Indian Private Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms G.B Pharma Pvt | Disposed |
| High Court of Madhya Pradesh | Court case (MCC) | Filed against the company by Nurtrica International Pvt. Ltd. | Disposed |
| High Court of Madhya Pradesh | Interim or miscellaneous application | Filed against the company by Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex, Bandra (E), Mumbai-400051 | Disposed |
To see the full case history of DCM Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DCM Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
DCM Pharma Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
DCM Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAHCD7400K1ZT | Chandigarh | Active | 27 Jun 2020 |
To see the full GST registrations and return filing status of DCM Pharma Private Limited, buy the company report.
Recent activity
DCM Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Abhinav Aggarwal was appointed as Director on 13 May 2020.
AGM
Dcm Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dcm Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.67 Lakh with Charge ID 101047048 was registered on 05 Feb 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Lakh with Charge ID 101049518 was registered on 31 Dec 2024.
Appointed
Abhinav Aggarwal was appointed as Director.
Appointed
Sumit Kumar was appointed as Director.
Incorporation
13 May 2020
Dcm Pharma Private Limited was registered on 13 May 2020 with Roc Chandigarh & aged 6 years 5 months as per MCA records.
Frequently asked questions
DCM Pharma is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 May 2020 (6+ years old) and is registered under CIN U51909CH2020PTC042985.
DCM Pharma has 2 current directors:
- Sumit Kumar - Director
- Abhinav Aggarwal - Director
The latest financial statements of DCM Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of DCM Pharma is 04AAHCD7400K1ZT, registered in Chandigarh.
The CIN (Corporate Identification Number) of DCM Pharma is U51909CH2020PTC042985. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DCM Pharma has 5 court cases on record: 3 filed by the company and 2 filed against it. Most are in the district courts.
DCM Pharma was incorporated on 13 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of DCM Pharma by revenue are Exclusive Automobiles Private Limited, Naturegro Seeds Private Limited, Collate Dealers Private Limited, Securex Solutions Private Limited, Rustagi Infrastructure Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Abhinav Aggarwal was appointed as Director on 13 May 2020. Sumit Kumar was appointed as Director on 13 May 2020.
Yes, DCM Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
DCM Pharma can be reached through the website formulations.in. Its registered office is in Chandigarh, India.